Increased Risk of Cutaneous Immune-Related Adverse Events in Patients Treated with Talimogene Laherparepvec and Immune Checkpoint Inhibitors: A Multi-institutional Cohort Study
收藏Mendeley Data2026-04-18 收录
官方服务:
资源简介:
Supplemental file
创建时间:
2023-02-14



